Skip to content

Author

M. Goulielmaki

We have 2 of 49 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

The heterogeneous and dynamic immune-tumor interface in breast cancer

BCa progression therefore, reflects a balance between immune activation and suppression, governed by spatial organization and cellular stratification within the tumor microenvironment (TME).

C. N. Baxevanis, M. Goulielmaki, A. Gritzapis et al. · 0 citations
Review Open access Jul 2026

Immunoediting and precision biomarkers in prostate cancer: The emerging role of liquid biopsy, immune contexture and HLA genotype (Review)

The present review examines the emerging role of germline human leukocyte antigen class I genotype as a prognostic and predictive biomarker, explicitly integrating it with tissue-based immune contexture and liquid biopsy readouts by proposing immunoediting as a unifying mechanistic framework that links allele-specific...

C. N. Baxevanis, S. Stokidis, S. Fortis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.